Compare PACB & PNNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PACB | PNNT |
|---|---|---|
| Founded | 2000 | 2007 |
| Country | United States | United States |
| Employees | 575 | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Finance: Consumer Services |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 459.0M | 397.7M |
| IPO Year | 2010 | 2007 |
| Metric | PACB | PNNT |
|---|---|---|
| Price | $1.37 | $4.90 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 5 | 5 |
| Target Price | $2.20 | ★ $5.85 |
| AVG Volume (30 Days) | ★ 5.9M | 818.9K |
| Earning Date | 05-04-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 19.01% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $93,468,000.00 | N/A |
| Revenue This Year | $11.22 | N/A |
| Revenue Next Year | $12.41 | N/A |
| P/E Ratio | ★ N/A | $13.14 |
| Revenue Growth | ★ 3.04 | N/A |
| 52 Week Low | $0.85 | $4.84 |
| 52 Week High | $2.73 | $7.53 |
| Indicator | PACB | PNNT |
|---|---|---|
| Relative Strength Index (RSI) | 33.19 | 31.83 |
| Support Level | $1.36 | $4.84 |
| Resistance Level | $1.73 | $6.18 |
| Average True Range (ATR) | 0.12 | 0.14 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 5.66 | 11.84 |
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.
Pennant Park Investment Corp is a closed-end, non-diversified investment company. Its investment objective is to generate current income and capital appreciation also seeking to preserve capital through debt and equity investments. The company focuses on investing in United States middle-market companies that offer attractive risk-reward to investors and to create a diversified portfolio that includes senior secured debt, mezzanine debt, and equity investments. It generates majority of its revenue from interest and dividends received from investments made.